Why does counting exon inclusion and skipping signals matter for target validation?

Scientific Value: Enables interrogation of therapeutic hypotheses by linking specific splice isoforms to cell-type-specific expression patterns in disease-relevant brain regions.
Operational Value: Provides a robust, sensitive assay system for examining alternative splicing patterns in situ within tissue slices, reducing reliance on dissociated cell models that lose spatial context.

Counting signals from exon inclusion- and skipping-specific probes enables calculation of percent spliced in (PSI) values, providing a quantitative measure of isoform expression in specific brain regions. This supports target validation by linking splice variant abundance to anatomical context and disease relevance.

How does isolating the independent variable (probe specificity) fit the discovery pipeline?

Using exon junction probes that distinguish between inclusion and skipping isoforms isolates the splicing event as the independent variable, enabling clear attribution of signal changes to specific molecular alterations. This fits early discovery by clarifying mechanism-of-action for splicing-modulating compounds.

What quantitative dependent variable measurements enable PSI calculation?

The number of red punctate dots from inclusion-specific and skipping-specific probes, along with total signal, serves as the dependent variable for PSI calculation. These counts are normalized to determine the percentage of transcripts containing the exon across cell populations in defined brain regions.

Why do replication requirements matter for cross-functional collaboration?

Replicating the assay on adjacently cut tissue sections processed identically ensures that signal differences reflect true biological variation rather than technical artifacts. This supports reliable data sharing between discovery, preclinical, and translational teams for consistent target assessment.

What statistical analysis capabilities are required before implementation?

Implementation requires the ability to quantify and compare signal counts across biological replicates and anatomical regions, using methods such as mean PSI with standard deviation or confidence intervals. Basic statistical comparison of PSI values between conditions (e.g., wild type vs. mutant) is necessary to assess significant splicing changes.